Eshelman ranked No. 1 in pharmacy research funding

The school earned the top spot from the American Association of Colleges of Pharmacy with more than $92 million in grants in FY23.

Exterior photo of Eshelman School of Pharmacy building in the daytime.
(Jon Gardiner/UNC-Chapel Hill)

The UNC Eshelman School of Pharmacy is the No. 1 pharmacy school in the nation in NIH research funding and total funding, according to rankings from the American Association of Colleges of Pharmacy.

It’s the first time Eshelman has earned the No. 1 status. The school earned more than $92 million in total grants for fiscal year 2023.

The annual rankings compile data from more than 140 pharmacy schools across the country.

“This is a credit to our faculty, staff and students who have been pursuing rigorous, innovative and impactful scholarship that is being rewarded by funders,” said Eshelman Dean Angela Kashuba. “This is a testament to them as leaders and innovators in pharmacy and pharmaceutical sciences.”

Eshelman’s research enterprise has a culture of collaboration, partnering across the campus, state, nation and globe to advance research, education and practice.

Recently, the NIH awarded $2.4 million to Delesha Carpenter, professor and executive vice chair of the Division of Pharmaceutical Outcomes and Policy, for a project on racial disparities in naloxone access. Juliane Nguyen, professor and vice chair of the Division of Pharmacoengineering and Molecular Pharmaceutics, received a $1.9 million R01 to develop a non-invasive, living drug depot to treat heart attacks.

In April, Eshelman was named the No. 1 pharmacy school in the county, according to U.S. News and World Report.